Get started Log in

MXCT — MaxCyte Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Market Cap
£170.78m
Enterprise Value
£68.52m
Revenue
$38.63m

MaxCyte, Inc. MaxCyte, Inc. - MXCR - Result of AGM
31/10/2018 16:25
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Dosing Begins in First Clinical Trial of MCY-M11
10/10/2018 07:00
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of AGM
08/10/2018 07:00
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Results for the Half Year ended 30 June 2018
24/09/2018 07:01
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Grant of Options
10/09/2018 07:00
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of Half Year Results
03/09/2018 07:01
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Director/PDMR Shareholding
26/07/2018 17:33
Brief: Maxcyte Gets Investigational New Drug Clearance From U.S FDA
16/07/2018 07:24
Brief: MaxCyte Posts H1 Revenue Of $6.9 Mln
16/07/2018 07:21
MaxCyte, Inc. MaxCyte, Inc. - MXCR - FDA IND Clearance for First Clinical Programme
16/07/2018 07:00
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Trading Update
16/07/2018 07:00
RCS - MaxCyte, Inc. - MaxCyte & NIH enter CRADA for Sickle Cell Disease
11/06/2018 07:00
RCS - MaxCyte, Inc. - Preclinical Results at ASGCT Annual Meeting
21/05/2018 07:01
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of AGM and Annual Report
30/04/2018 07:02
Brief: Maxcyte Appoints Claudio Dansky Ullmann As Chief Medical Officer
25/04/2018 12:10
RCS - MaxCyte, Inc. - CMO Appointment
25/04/2018 07:01
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Final Results for Year Ended 31 December 2017
04/04/2018 07:00
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of Full Year Results
15/03/2018 07:01
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Director/PDMR Shareholding
28/02/2018 17:00
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Grant of Options
15/02/2018 07:01